EFFICACY AND SAFETY OF RAVULIZUMAB IN A PHASE 2 RANDOMIZED CONTROLLED TRIAL IN IgA NEPHROPATHY

  Back

14 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-1197, Poster Board= SUN-035

Jonathan Barratt Poster Presenter